Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation
- PMID: 35831256
- DOI: 10.1111/ped.15233
Gastrointestinal tract involvement of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after cord blood transplantation
Keywords: Epstein-Barr virus-associated post-transplant lymphoproliferative disorder; gastrointestinal tract; neuroblastoma; rituximab; unrelated cord blood transplantation.
References
-
- Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Post-transplant lymphoproliferative disorders. Nat. Rev. Dis. Primers 2016; 2 (1): 15088.
-
- Hussein K, Tiede C, Maecker-Kolhoff B, Kreipe H. Posttransplant lymphoproliferative disorder in pediatric patients. Pathobiology 2013; 80: 289-96.
-
- L'Huillier AG, Dipchand AI, Ng VL et al. Posttransplant lymphoproliferative disorder in pediatric patients: Characteristics of disease in EBV-seropositive recipients. Transplantation 2019; 103: e369-74.
-
- Ali S, AlThubaiti S, Renzi S et al. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation. Pediatr. Transplant. 2019; 23: e13319.
-
- Gong JZ, Bayerl MG, Sandhaus LM et al. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Am. J. Surg. Pathol. 2006; 30: 328-36.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources